-+ 0.00%
-+ 0.00%
-+ 0.00%

Rongchang Biotech (09995)'s net profit for the first three quarters was 5.273 billion yuan

Zhitongcaijing·10/29/2026 11:25:02
Listen to the news

According to Zhitong Finance App, Rongchang Biotech (09995) announced that for the first three quarters of 2026, operating income was 6.764 billion yuan, an increase of 293.28% over the previous year; net profit attributable to shareholders of listed companies was 5.273 billion yuan, loss of 551 million yuan for the same period last year; and basic earnings per share were 9.41 yuan.